Gabriel Elias Corrêa-Oliveira1, Julia Lopes do Amaral1, Benedito Antônio Lopes da Fonseca2, Cristina Marta Del-Ben1. 1. Serviço de Emergências Psiquiátricas, Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. 2. Divisão de Moléstias Infecciosas e Tropicais, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Zika virus (ZIKV), a flavivirus primarily transmitted by Aedes mosquitoes, represents a major public health concern. ZIKVinfection, previously considered a self-limited febrile exanthematic disease, leads to serious neurologic complications.1Microcephaly and extensive brain damage can result from congenital ZIKVinfection. An association with Guillain-Barre Syndrome was suggested after the French Polynesia outbreak,2 and reports from endemic areas suggest that acute ZIKVinfection leads to numerous central nervous system (CNS) complications. Considering the complexity of CNS function, we can expect a variety of clinical manifestations, even purely psychiatric symptoms.A 17-year-old boy was transferred to our psychiatric emergency ward for evaluation of a first-episode psychosis (FEP). He had no significant health history or previous psychiatric history. Ten days prior to admission, he suddenly presented paranoid delusions and vivid auditory, somatic and olfactory hallucinations. He showed intense anxiety and panic-like symptoms, alternating with moments of inadequate behavioral disinhibition. Symptoms also included sleeplessness, increased speech production, vocal mannerisms and refusal to eat. A distinct period of altered mood was negated. Upon admission he was fully conscious with no attention deficits, disoriented about the time and place, afraid, suspicious and speaking incoherently. Physical and neurological exams were otherwise normal. Initial workup included hematological, toxicological, neuroradiologic and electroencephalographic assessments, which were all within normal range. A febrile rash – followed by pruritus, myalgia, arthralgia, periocular pain and posterior cervical adenopathy, which began 14 days before the onset of the behavioral symptoms and remitted after a week – was then reported by his parents.We extended the investigation to rule out other medical conditions leading to the psychotic episode. All CSF parameters were within the normal range. In peripheral blood we detected positive dengue virus (DENV) in ELISA, IgM, and IgG tests; the NS1 antigen was undetectable and RT-PCR was negative for DENV. RT-PCRs for ZIKV resulted positive in multiple blood samples. An intense cross-reaction was observed across DENV and ZIKV ELISA titers,3,4 leading us to conclude that this was the case. After five days of Haloperidol with no response, the prescription was changed to Risperidone 2 mg/day and remission was achieved in three days. The patient was discharged and medication was tapered off after 3 weeks. No relapse in symptoms was noted during one year of follow-up in our specialized FEP outpatient service.To the best of our knowledge, this is the first report in which psychiatric symptoms were the only complication of acute ZIKVinfection. There is much evidence of psychiatric symptomatology in viral infections. Dengue-related manic and psychotic episodes have been described in which symptoms suggesting encephalitis or encephalopathy were not seen – thus supporting flavivirus’ role in inducing purely behavioral symptoms. Cases in which DENVinfections have led to neuropsychiatric complications are numerous, well established in the literature and more commonly diagnosed than in regular clinical practice.5Neuroimmune mechanisms leading to psychosis during acute CNS stress is an open and prolific field for research. On the clinical front, mental health professionals dealing with emergency psychiatry and FEP must have a high grade of suspicion to avoid underrecognizing particular – and self-limited – conditions.
Authors: Karin Stettler; Martina Beltramello; Diego A Espinosa; Victoria Graham; Antonino Cassotta; Siro Bianchi; Fabrizia Vanzetta; Andrea Minola; Stefano Jaconi; Federico Mele; Mathilde Foglierini; Mattia Pedotti; Luca Simonelli; Stuart Dowall; Barry Atkinson; Elena Percivalle; Cameron P Simmons; Luca Varani; Johannes Blum; Fausto Baldanti; Elisabetta Cameroni; Roger Hewson; Eva Harris; Antonio Lanzavecchia; Federica Sallusto; Davide Corti Journal: Science Date: 2016-07-14 Impact factor: 47.728
Authors: Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Jason O Velez; Amy J Lambert; Alison J Johnson; Stephanie M Stanfield; Mark R Duffy Journal: Emerg Infect Dis Date: 2008-08 Impact factor: 6.883
Authors: Chandy C John; Hélène Carabin; Silvia M Montano; Paul Bangirana; Joseph R Zunt; Phillip K Peterson Journal: Nature Date: 2015-11-19 Impact factor: 49.962
Authors: Sylvie Janssens; Michael Schotsaert; Rahul Karnik; Vinod Balasubramaniam; Marion Dejosez; Alexander Meissner; Adolfo García-Sastre; Thomas P Zwaka Journal: mSystems Date: 2018-02-06 Impact factor: 6.496
Authors: Pei-Ying Kobres; Jean-Paul Chretien; Michael A Johansson; Jeffrey J Morgan; Pai-Yei Whung; Harshini Mukundan; Sara Y Del Valle; Brett M Forshey; Talia M Quandelacy; Matthew Biggerstaff; Cecile Viboud; Simon Pollett Journal: PLoS Negl Trop Dis Date: 2019-10-04